Doxorubicin cardiomyopathy: evaluation by phonocardiography, endomyocardial biopsy, and cardiac catheterization
about
Human immunodeficiency virus & cardiovascular riskAtrial natriuretic peptide as a marker for doxorubicin-induced cardiotoxic effectsEffect of metoprolol on activity of beta-adrenoceptor coupled to guanine nucleotide binding regulatory proteins in adriamycin-induced cardiotoxicityAnthracycline cardiomyopathy in children: report of two casesCyclophosphamide-induced cardiomyopathy: a report of two cases and review of the English literatureAmsacrine is safe and effective therapy for patients with myocardial dysfunction and acute leukemiaA phase I study of 4'-0-tetrahydropyranyladriamycin. Clinical pharmacology and pharmacokineticsLong term doxorubicin cardiotoxicity in childhood: non-invasive evaluation of the contractile state and diastolic filling.Prevention of doxorubicin cardiac toxicity in the mouse by N-acetylcysteineAggressive management of doxorubicin-induced cardiomyopathy associated with 'low' doses of doxorubicinAnthracycline- and trastuzumab-induced cardiotoxicity: a retrospective studyCardiac imaging approaches to evaluate drug-induced myocardial dysfunctionCardio-oncology: a new medical issue.Anthracycline-induced cardiomyopathy: long-term effects on myocardial cell integrity, cardiac adrenergic innervation and fatty acid uptake.Prevention and treatment of cardiomyopathy and heart failure in patients receiving cancer chemotherapy.Quantitative evaluation of left ventricular systolic function by Doppler echocardiographic techniques.Anthracyclines: cardiotoxicity and its prevention.Identification of protein targets underlying dietary nitrate-induced protection against doxorubicin cardiotoxicityDietary nitrate supplementation protects against Doxorubicin-induced cardiomyopathy by improving mitochondrial function.An A,B,C,D of cancer chemotherapy.Anthracycline-associated cardiotoxicity in survivors of childhood cancer.Anthracycline cardiotoxicity: prevalence, pathogenesis and treatmentChemotherapy-induced cardiotoxicity: current practice and prospects of prophylaxis.Cardiac damage induced by 2-amino-3-methyl-imidazo[4,5-f]quinoline in nonhuman primates.Dietary inorganic nitrate alleviates doxorubicin cardiotoxicity: mechanisms and implications.Pathophysiology of anthracycline- and radiation-associated cardiomyopathies: implications for screening and prevention.Long-term effects of adjuvant chemotherapy in breast cancer.Anthracycline cardiotoxicity.Cardiotoxicity as a dose-limiting factor in a schedule of high dose bolus therapy with interleukin-2 and alpha-interferon. An unexpectedly frequent complication.Myocardial disease in human immunodeficiency virus (HIV) infection: a review.Infectious and Non-infectious Etiologies of Cardiovascular Disease in Human Immunodeficiency Virus InfectionPredicting and preventing the cardiotoxicity of cancer therapy.Cardiomyopathy associated with cancer therapy.Cardiotoxicity due to chemotherapy: role of cardiac imaging.Modulation of cardiovascular toxicity in Hodgkin lymphoma: potential role and mechanisms of aerobic trainingBeet root juice protects against doxorubicin toxicity in cardiomyocytes while enhancing apoptosis in breast cancer cells.Visnagin-a new protectant against doxorubicin cardiotoxicity? Inhibition of mitochondrial malate dehydrogenase 2 (MDH2) and beyond.Cardio-Oncology: Progress in Diagnosis and Treatment of Cardiac Dysfunction.Cardiotoxicity and cardiomyopathy in children and young adult survivors of hematopoietic stem cell transplant.Adriamycin (doxorubicin) cardiotoxicity: a review.
P2860
Q22241184-9D46F442-A0C2-436F-B42A-65EDB86AD6A1Q28318932-BBA749FA-DAF6-440D-8991-C185C6C51050Q28321527-A835BD3E-CFBA-47BD-9AF1-FCDFFF15C8D9Q28323816-CDECBEDA-FEDF-400D-B2BC-53883BEA551DQ28324933-EA47CCA1-251B-4942-A138-A67D5546620EQ28327598-7FA38B5D-A8E5-4D28-A311-AE9F2A977F37Q28331720-D3C45BDC-4817-4F1F-A547-68EE5BE3A15EQ28361151-2A79102F-56A8-4A41-BAAB-F00D63BFF385Q28366936-0EF6EA99-3DED-4E55-BFEA-C79586162DF5Q28368331-E59021D8-F7AC-48C6-994F-E9D0F881C300Q30276527-9795FE5F-E1E3-4115-823A-51B14B830DF6Q30446453-08F6A522-DB7E-4E80-9790-2E3172608CC5Q30471284-DDA7385F-8B0A-413A-8713-BD47575FA497Q31894914-CFE6F8CE-C352-4DB5-9443-98407759A1CFQ33386386-C5161582-C8EC-4EFF-B1C7-08BFA67D4E8DQ33566168-00D32C28-21CD-467C-BCC7-69BF08552F46Q33625243-B4A5E946-4984-4CEB-963F-A036C84F9A20Q33798502-334AD7CA-AECA-4178-A4A7-8FCA5697F7B3Q34022675-7DC71E60-75B4-40F7-A0B5-D47D20B22E42Q34052652-64EE2C2A-F5EE-4CB7-9A1B-FEAD61E189A5Q34626238-99EB3A90-B45D-44D3-A886-CA0A3D45BDCBQ34639876-7794CBE0-C7C7-4533-9532-4C20549752A1Q34659375-EA1EE743-0B73-4CB9-9B42-5E23BEBF55B8Q35031855-1F356FE8-188C-43C8-A81B-F2188E3F70CFQ35989515-0EEB841D-096B-4865-8822-0CA4275CE39AQ36108829-7349CD7B-97B1-4735-81A1-B2CDFC6826E7Q36286967-6FE45BD6-A07B-40CE-B862-AC3AD1CE2BD6Q36624983-74AEEB94-A3D3-426D-83B3-362556638CECQ36726115-96DBE46E-74D8-4DF0-BAD8-47ED81A2A1DAQ37103246-EBCBBE5A-9D75-4B97-8F2B-7273C1727164Q37195784-3B64EAFF-7E2B-45E1-B65A-5AF9922C292EQ37230408-3B62EF9B-E13B-46B7-9E74-EA8B7252A3D1Q38242641-A6DFFBF6-712E-4224-9A86-85FCCDAAF0ECQ38343043-BBE40D10-3AF5-4E59-B488-3C29E2765EC9Q38559153-A382B157-F4D2-44D9-84CA-206B3792719EQ38749854-207ED5B8-4378-4F51-AC9E-DC0E08CFDD44Q38800300-8F60663B-9542-4557-B8D3-5E763218FED6Q39078275-A27EB61C-7486-4571-B7A3-A5A742ED1274Q39270177-987BE0AE-BF25-4B6F-8301-211E6D64E8B0Q39322668-BF483878-052F-4727-88E5-BFF9B572AE44
P2860
Doxorubicin cardiomyopathy: evaluation by phonocardiography, endomyocardial biopsy, and cardiac catheterization
description
1978 nî lūn-bûn
@nan
1978 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1978 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1978年の論文
@ja
1978年論文
@yue
1978年論文
@zh-hant
1978年論文
@zh-hk
1978年論文
@zh-mo
1978年論文
@zh-tw
1978年论文
@wuu
name
Doxorubicin cardiomyopathy: ev ...... y, and cardiac catheterization
@ast
Doxorubicin cardiomyopathy: ev ...... y, and cardiac catheterization
@en
Doxorubicin cardiomyopathy: ev ...... y, and cardiac catheterization
@nl
type
label
Doxorubicin cardiomyopathy: ev ...... y, and cardiac catheterization
@ast
Doxorubicin cardiomyopathy: ev ...... y, and cardiac catheterization
@en
Doxorubicin cardiomyopathy: ev ...... y, and cardiac catheterization
@nl
prefLabel
Doxorubicin cardiomyopathy: ev ...... y, and cardiac catheterization
@ast
Doxorubicin cardiomyopathy: ev ...... y, and cardiac catheterization
@en
Doxorubicin cardiomyopathy: ev ...... y, and cardiac catheterization
@nl
P2093
P3181
P1476
Doxorubicin cardiomyopathy: ev ...... y, and cardiac catheterization
@en
P2093
J R Daniels
M E Billingham
M R Bristow
P304
P3181
P356
10.7326/0003-4819-88-2-168
P407
P577
1978-02-01T00:00:00Z